Multi-parametric profiling network based on gene expression and phenotype data: a novel approach to developmental neurotoxicity testing.
The establishment of more efficient approaches for developmental neurotoxicity testing (DNT) has been an emerging issue for children's environmental health. Here we describe a systematic approach for DNT using the neuronal differentiation of mouse embryonic stem cells (mESCs) as a model of fetal programming. During embryoid body (EB) formation, mESCs were exposed to 12 chemicals for 24 h and then global gene expression profiling was performed using whole genome microarray analysis. Gene expression signatures for seven kinds of gene sets related to neuronal development and neuronal diseases were selected for further analysis. At the later stages of neuronal cell differentiation from EBs, neuronal phenotypic parameters were determined using a high-content image analyzer. Bayesian network analysis was then performed based on global gene expression and neuronal phenotypic data to generate comprehensive networks with a linkage between early events and later effects. Furthermore, the probability distribution values for the strength of the linkage between parameters in each network was calculated and then used in principal component analysis. The characterization of chemicals according to their neurotoxic potential reveals that the multi-parametric analysis based on phenotype and gene expression profiling during neuronal differentiation of mESCs can provide a useful tool to monitor fetal programming and to predict developmentally neurotoxic compounds.
Health Risk Research Section, Research Center for Environmental Risk, National Institute for Environmental Studies, 16-2 Onogawa, Tsukuba 305-8506, Japan; E-Mails:  nagano.reiko@tasc-nt.or.jp  (R.N.);  akanuma.hiromi@nies.go.jp  (H.A.);  y_qin@envhlth.k.u-tokyo.ac.jp  (X.-Y.Q.);  Toyoshiba_Hiroyoshi@takeda.co.jp  (H.T.).
Reiko
R
Nagano
Hiromi
H
Akanuma
Xian-Yang
XY
Qin
Satoshi
S
Imanishi
Hiroyoshi
H
Toyoshiba
Jun
J
Yoshinaga
Seiichiroh
S
Ohsako
Hideko
H
Sone
D000818:Animals; D001321:Autistic Disorder / Q000235:genetics / Q000378:metabolism / Q000473:pathology; D001499:Bayes Theorem; D002478:Cells, Cultured; D058732:Embryoid Bodies / Q000166:cytology / Q000187:drug effects / Q000378:metabolism*; D053595:Embryonic Stem Cells / Q000166:cytology; D020869:Gene Expression Profiling; D018507:Gene Expression Regulation, Developmental / Q000187:drug effects; D051379:Mice; D055495:Neurogenesis / Q000187:drug effects; D009474:Neurons / Q000166:cytology; D009930:Organic Chemicals / Q000633:toxicity; D010300:Parkinson Disease / Q000235:genetics / Q000378:metabolism / Q000473:pathology; D010641:Phenotype; D025341:Principal Component Analysis
D009930:Organic Chemicals